Biocept (BIOC)

Biocept's (BIOC) CEO Michael Nall on Q1 2017 Results - Earnings Call Transcript
May 13, 2017 | Price: Free! | Source: Seeking Alpha

Biocept's (BIOC) CEO Michael Nauman on Q1 2017 Results - Earnings Call Transcript
March 7, 2017 | Price: Free! | Source: Seeking Alpha

Recent filings

Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - May 15, 2017

Securities to be offered to employees in employee benefit plans - May 15, 2017

Biocept Reports First Quarter 2017 Financial Results - May 11, 2017

Biocept: With Respect To Restricted Awards, The Restricted Period Sha - May 5, 2017

Notice of Exempt Offering of Securities, item 06b - April 10, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept releases salary data. CEO sees compensation fall -14% - March 30, 2017

Biocept Announces Pricing Of $9.3 Million Financing - March 30, 2017

Biocept director just picked up 5,667 shares - March 29, 2017

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - March 29, 2017

Biocept Just Filed Its Annual Report: 12. Net Loss per Co... - March 28, 2017

Shareholder Director - March 23, 2017

CFO of Biocept was just granted 16,383 options - March 22, 2017

Biocept's CEO & President was just granted 16,333 options - March 22, 2017

Biocept Reports Fourth Quarter And Full Year 2016 Financial Results - March 7, 2017

Biocept's Sr VP Comm. Operations was just granted 50,000 options - Feb. 28, 2017

Biocept's Sr VP Comm. Operations just declared owning 2,900 shares of Biocept - Feb. 16, 2017

Biocept’S Ceo Issues Letter To Stockholders - Feb. 9, 2017

Bin Li just provided an update on activist position in Biocept - Jan. 27, 2017

Major owner of Biocept just disposed of 1,681,000 shares - Jan. 26, 2017

On November - Jan. 25, 2017

Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Jan. 11, 2017

Notice of Delisting or - Dec. 2, 2016

Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - Nov. 10, 2016

Biocept Reports 2016 Third Quarter Financial Results - Nov. 9, 2016

Termination of a Material Definitive - Nov. 4, 2016

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Oct. 28, 2016

Major owner of Biocept just declared owning 1,681,000 shares of Biocept - Oct. 24, 2016

Daniel V. Tierney just provided an update on share ownership of Biocept - Oct. 24, 2016

Biocept director just picked up 4,545 shares - Oct. 21, 2016

Biocept director just picked up 90,909 shares - Oct. 21, 2016

Biocept director just picked up 227,272 shares - Oct. 21, 2016

CFO of Biocept just picked up 36,363 shares - Oct. 21, 2016

Major owner of Biocept just picked up 227,272 shares - Oct. 21, 2016

Biocept director just picked up 13,636 shares - Oct. 21, 2016

Biocept's SR VP of R&D and CSO just picked up 45,000 shares - Oct. 21, 2016

Biocept director just picked up 20,000 shares - Oct. 21, 2016

Biocept director just picked up 50,000 shares - Oct. 21, 2016

Biocept's Sr VP & Sr Med Director just picked up 10,000 shares - Oct. 21, 2016

Biocept's CEO & President just picked up 36,363 shares - Oct. 21, 2016

Bin Li just provided an update on activist position in Biocept - Oct. 20, 2016

Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Oct. 17, 2016

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Oct. 14, 2016

Post-effective amendment adding exhibits to registration statement [Rule 462(d)] - Oct. 14, 2016

Biocept Just Received a Notice of Effectiveness - Oct. 13, 2016

General form for registration of securities under the Securities Act of 1933 - Oct. 6, 2016

General form for registration of securities under the Securities Act of 1933 - Sept. 29, 2016

Biocept: Risks Relating To Our Financial Condition And Capital Requirements - Sept. 29, 2016

Other definitive proxy statements - Aug. 31, 2016

General form for registration of securities under the Securities Act of 1933 - Aug. 12, 2016

Other preliminary proxy statements - Aug. 11, 2016

Biocept Just Filed Its Quarterly Report: 9. Net Loss per Com... - Aug. 5, 2016

Securities to be offered to employees in employee benefit plans - Aug. 5, 2016

Biocept Reports 2016 Second Quarter Financial Results - Aug. 2, 2016

CFO of Biocept just picked up 75,000 shares - Aug. 1, 2016

Departure of Directors or Certain - Aug. 1, 2016

CFO of Biocept just declared ownership of no shares of Biocept - July 27, 2016

Biocept Appoints Timothy C. Kennedy As Chief Financial Officer And Senior Vice President Of Operations - July 27, 2016

Biocept's SR VP of R&D and CSO just picked up 50,000 shares - July 7, 2016

Departure of Directors or Certain - July 7, 2016

Biocept's Sr VP & Sr Med Director just picked up 50,000 shares - July 7, 2016

Biocept's CEO & President just picked up 75,000 shares - July 7, 2016

Submission of Matters to a Vote of Security - June 29, 2016

Notice of Delisting or - June 17, 2016

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - May 26, 2016

Biocept releases salary data. CEO sees compensation fall -29% - May 18, 2016

Biocept Just Filed Its Quarterly Report: 9. Net Loss per Com... - May 13, 2016

Biocept Reports 2016 First Quarter Financial Results - May 12, 2016

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - May 10, 2016

Biocept Just Received a Notice of Effectiveness - May 10, 2016

Statement of acquisition of beneficial ownership by individuals - May 6, 2016

Biocept director just picked up 100,000 shares - May 5, 2016

Biocept director just picked up 50,000 shares - May 5, 2016

Major owner of Biocept just declared owning 14,012 shares of Biocept - May 5, 2016

Major owner of Biocept just picked up 614,273 shares - May 5, 2016

Biocept director just picked up 25,000 shares - May 5, 2016

Post-Effective amendments for registration statement - May 4, 2016

Prospectus [Rule 424(b)(5)] - April 29, 2016

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - April 29, 2016

Biocept, Inc. Announces Pricing Of $5 Million Public Offering Of Common Stock And Warrants - April 29, 2016

Post-Effective amendments for registration statement - April 29, 2016

Biocept: Documents Incorporated By Reference TABLE OF CONTENTS Explanatory Note Part III Item 10 - April 25, 2016

Annual report [Section 13 and 15(d), not S-K Item 405] - March 10, 2016

Prospectus [Rule 424(b)(3)] - March 10, 2016

BioClinica: Biocept Reports 2015 Fourth Quarter And Full Year Financial Results - March 9, 2016

BioClinica's VP Commercial Operations was just granted 17,500 options - March 1, 2016

BioClinica's CEO & President just picked up 13,348 shares - March 1, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Frigate Ventures LP 652,400 0.6 March 31, 2017
2. GOLDMAN CAPITAL MANAGEMENT INC 100,000 0.2 March 31, 2017
3. WealthTrust Axiom LLC 140,000 0.1 March 31, 2017
4. GARRISON BRADFORD & ASSOCIATES INC 25,880 0.1 March 31, 2017
5. NORTHERN TRUST CORP 16,490 N/A March 31, 2017
6. GEODE CAPITAL MANAGEMENT, LLC 27,210 N/A March 31, 2017
7. UBS Group AG 1,189 N/A March 31, 2017
8. RAYMOND JAMES & ASSOCIATES 21,000 N/A March 31, 2017
9. Creative Planning 381 N/A March 31, 2017
10. VANGUARD GROUP INC 697,605 N/A March 31, 2017
11. Mount Lucas Management LP 14,500 N/A March 31, 2017
12. Hudson Bay Capital Management LP 399,600 N/A March 31, 2017
13. SUSQUEHANNA INTERNATIONAL GROUP, LLP 798,469 N/A March 31, 2017
14. BlackRock Institutional Trust Company, N.A. 56,732 N/A Dec. 31, 2016
15. MORGAN STANLEY 334 N/A Dec. 31, 2016
16. Advisory Services Network, LLC 334 N/A March 31, 2017
17. BlackRock Fund Advisors 1,498 N/A Sept. 30, 2016
18. State Street Corp 10,000 N/A March 31, 2017
19. ROYAL BANK OF CANADA 130 N/A Sept. 30, 2016
20. MetLife Securities, Inc 167 N/A Dec. 31, 2016
21. BlackRock Inc. 774,517 N/A March 31, 2017
22. MORGAN STANLEY 10,334 N/A March 31, 2017
23. Bank of New York Mellon Corp 35,979 N/A March 31, 2017
24. DEUTSCHE BANK AG\ 500 N/A March 31, 2017

Biocept (BIOC)

140
 


Feedback